Jessica Garcia: New Evidence on Thrombin Generation Patterns in Children with Hemophilia A
Jessica Garcia, Pediatric Hematologist, Hemostasis and Thrombosis Specialist at UT Southwestern Medical Center, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
”Honored to share our latest publication examining thrombin generation patterns in children with hemophilia A treated with extended half-life FVIII and non-FVIII therapies.
As treatment options expand, understanding how these therapies shape coagulation profiles in pediatric patients is essential for adequate, individualized care.
This work adds data where pediatric evidence has been limited.”
Title: Thrombin Generation in Pediatric Haemophilia A Patients on Extended Half-Life FVIII versus Non-FVIII Therapies
Authors: Jessica Garcia, Sean G Yates, Ravi Sarode, Guy Young, Ayesha Zia
Read the FullArticle on Haemophilia Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 31, 2026, 01:26Bringing the Voices of People With Bleeding Disorders to WHO Regional Discussions – World Federation of Hemophilia
-
Oct 31, 2026, 01:18A Clear Overview of Haemophilia A Treatments at SISET Congress – CRH French Reference Center for Hemophilia Lyon
-
Oct 31, 2026, 01:11Alexander Misono: Venous Ultrasound and Early Intervention in Deep Vein Thrombosis
-
Oct 31, 2026, 00:54How Has Human Evolution Shaped the Delicate Balance between Bleeding and Clotting? – Seminars in Thrombosis and Hemostasis
-
Oct 30, 2026, 23:56Laboratory Testing and Interpretation in Modern Haemophilia Care – South African Haemophilia Foundation
-
Oct 30, 2026, 23:45Jesus Ardila Novoa: Why HbF Levels and Hydroxyurea Absorption Matter in Children With SCA
-
Oct 30, 2026, 23:41Ana Paula Tagliari: Presenting a First-in-Human Experience With Mechanical Thrombectomy at TCT 2026
-
Oct 30, 2026, 23:38Alok Khorana: The Role of Platelets in Immune Suppression in Primary Brain Tumors
-
Oct 30, 2026, 23:34W. Alberto Sifuentes Giraldo: Temporal Structure of Cardiovascular and Thromboembolic Risk in AAV